case report aspiration during anesthesia glp-1 receptor agonist 2023 A narrative review of glucagon-like peptide-1 agonists prior to deep sedation or general GLP-1 agonists: a new hope

Trujillo, J.M., Nuffer, W., and Smith, B.A

Among the 12% of adults who have ever taken GLP-1 drugs, most report taking them, at least in part, to treat a chronic condition like diabetes or heart disease, with fewer saying they took them only to lose weight

Certainly with the GLP-1s coming on the market, weight loss was a nice surprise, said Sophia Thomas, doctor of nursing practice and a past president of the American Association of Nurse Practitioners

Over time, this may reduce weight gain, which is common in diabetes patients

Green chemistry is entering the peptide manufacturing conversation at scale for the first time

Inflammation Effects on Motivation and Motor Activity: Role of Dopamine